Effect of estrogen-gestagen combination therapy in advanced breast carcinoma with special reference to pulmonary metastases
Berndt, G.; Eckel, H.; Notter, G.; St Stender, H.
Strahlentherapie 141(5): 540-548
1971
ISSN/ISBN: 0039-2073 PMID: 5088730 Document Number: 485956
Document emailed within 1 workday
Related Documents
Aydinlik, S.; Lachnit-Fixson, U. 1977: Diane--a gestagen-estrogen combination with antiandrogenic effect Medizinische Monatsschrift 31(9): 425-429Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
Fazio, M.; Cavallero, P.; Rattalino, G.; Sartoris, S.; Vergnano, F. 1976: Combination drug-hormone therapy of the advanced stages of breast carcinoma Minerva Ginecologica 28(7-8): 623-629
Nomura, Y.; Tashiro, H.; Hisamatsu, K.; Toi, M. 1988: Effects of high-dose medroxyprogesterone acetate in advanced breast cancer, with special reference to prior endocrine therapy and hormone receptors Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 513-518
Hino, S.; Shintani, S.; Nonaka, T.; Hara, S.; Hamakawa, H. 2004: A case of advanced maxillary carcinoma with cervical lymph node metastases showing a complete response to the combination therapy of CDDP, TS-1 and radiation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(2): 215-217
Fernö, M.; Borg, A.; Erichsen, C.; Ingvar, C.; Jönsson, P.E. 1984: Estrogen and progesterone receptors in melanoma metastases with special reference to analytical methods and prognosis Anticancer Research 4(3): 179-182
Meiss, L.; Djandji, V.; Raute, M.; Kühn, W. 1974: Therapy of breast carcinoma. Surgical, radiologic and hormonal treatment of a patient with breast carcinoma metastases. Clinical course with regard to pre-terminal immunoglobulin and complement changes Fortschritte der Medizin 92(14): 615-616
Goretzlehner, G.; Rudolf, K.; Töwe, J. 1974: Long-term effects of the estrogen-gestagen combination preparation Ovosiston on glucose level in the insulin tolerance test Zentralblatt für Gynakologie 96(40): 1249-1253
Paone, J.F.; Abeloff, M.D.; Ettinger, D.S.; Arnold, E.A.; Baker, R.R. 1981: The correlation of estrogen and progesterone receptor levels with response to chemotherapy for advanced carcinoma of the breast Surgery Gynecology and Obstetrics 152(1): 70-74
Ebisui, C.; Okada, K.; Nushijima, Y.; Yanagisawa, T.; Okamura, S.; Fukuchi, N.; Murata, K.; Yokouchi, H.; Ohishi, K.; Tamai, M.; Kinuta, M. 2015: A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Treated with Combination Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1989-1991
Howell, A.; Harland, R.N.; Barnes, D.M.; Baildam, A.D.; Wilkinson, M.J.; Hayward, E.; Swindell, R.; Sellwood, R.A. 1987: Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment Cancer Research 47(1): 300-304
Ehara, K.; Tsutsumi, K.; Kinoshita, Y.; Ueno, M.; Mine, S.; Udagawa, H. 2008: A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(8): 1375-1378
Göretzlehner, G.; Herre, H.D.; Töwe, J. 1973: Effect of estrogen-gestagen combinations on carbohydrate and lipid-metabolism. 3. Effect of quinestrol-chlormadinone-acetate Zentralblatt für Gynakologie 95(52): 1831-1837
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Criscuolo, M.; Federico, M.; Sabbatini, R.; Rossi, E.; Piccinini, L.; Trentini, G.P. 1992: Prognostic factors in breast carcinoma with special reference to the C-erb-B2 gene: preliminary results Pathologica 84(1094): 87-91
Rubens, R.D.; Hayward, J.L. 1980: Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2922-2924
Soma, I.; Hasuike, Y.; Hayashi, N.; Fukuchi, N.; Izawa, H.; Yoshida, T.; Ebisui, C.; Sakita, I.; Fujimoto, T.; Koshino, T.; Izumiyama, K. 2004: A case report--Efficacy of combination therapy to unresectable advanced gall bladder carcinoma--palliative operation, hepatic arterial infusion therapy, and radiation therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(11): 1903-1905
McClelland, R.A.; Berger, U.; Miller, L.S.; Powles, T.J.; Jensen, E.V.; Coombes, R.C. 1986: Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer Cancer Research 46(8 Suppl): 4241s-4243s
Izumi, M.; Iino, Y.; Yokoe, T.; Inoue, T.; Yamada, T.; Kobayashi, I.; Andoh, T.; Yokota, T.; Iijima, T.; Morishita, Y. 1994: Advanced breast cancer with remarkable response to the combination therapy of mitoxantrone (MIT) and medroxyprogesteron acetate (MPA) after failure of anthracycline therapy: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 265-268
Manziuk, L.V.; Komov, D.V.; Khaĭlenko, V.A.; Artamonova, E.V.; Mikhina, Z.P.; Ermilova, V.D.; Abashin, S.I. 2001: Combination therapy of patients with locally advanced breast cancer Voprosy Onkologii 47(6): 740-743